文献速递中医儿科中药与中成药合理使用中医内科

整合代谢组-微生物组分析揭示小儿柴桂清热颗粒对幼年与成年急性上呼吸道感染大鼠的差异调控

An integrated metabolome-microbiome analysis revealed distinct regulatory effects of Xiaoer Chiqiao Qingre granules in young versus adult rats with acute upper respiratory tract infection.
PubMed 文献 · J Ethnopharmacol · 2026-01-16

该研究以幼年与成年急性上呼吸道感染大鼠模型,整合血清代谢组学与16S rDNA测序,评估小儿柴桂清热颗粒的调节作用。结果显示两年龄组均有效,但分别鉴定出37个幼年特异与18个成年特异血清生物标志物,肠道菌群调控模式及代谢通路存在年龄差异。结论提示支持儿科专用研究。

要点

  • 两年龄组均抗急性上呼吸道感染有效,但代谢与菌群调控模式不同。
  • 幼年组主要调节半胱氨酸与蛋氨酸等氨基酸代谢通路。
  • 成年组主要关联戊糖与葡萄糖醛酸互变及嘌呤代谢通路。

核心结论

  • 小儿柴桂清热颗粒对幼年与成年急性上呼吸道感染大鼠的血清代谢组和肠道菌群具有差异调控作用。
  • 结果提示支持该药在儿童中临床应用需儿科专属研究。

研究设计与样本

  • 构建急性上呼吸道感染大鼠模型,幼年大鼠作为儿科发育替代模型。
  • 评估血清炎症因子、肺组织病理与免疫组化,并行整合血清代谢组学与16S rDNA测序。

主要发现

  • 两年龄组均表现出抗急性上呼吸道感染疗效。
  • 代谢物定量鉴定出37个幼年特异和18个成年特异血清生物标志物。
  • 两年龄组均调节肠道菌群多样性并提高群落丰富度。
  • 幼年组Subdoligranulum、Marvinbryantia、Anaerostipes、Bacillus和Dubosiella_ag显著恢复,成年组Escherichia-shigella、Parabacteroides和Subdoligranulum明显恢复。
  • 幼年组主要调控半胱氨酸与蛋氨酸相关氨基酸代谢,成年组主要关联戊糖与葡萄糖醛酸互变及嘌呤代谢,甘油磷脂代谢为两组共享通路。

临床怎么用

  • 临床应关注小儿柴桂清热颗粒在儿童与成人中代谢和菌群调控的差异。
  • 儿科用药决策可参考幼年特异性生物标志物与菌群变化,但仍需儿科专属研究验证。

局限性

  • 原文未报告样本量、具体剂量、P值等数值。
  • 幼年大鼠作为儿科发育替代模型,结论外推至儿童需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Xiaoer Chiqiao Qingre Granules (XECQ), officially recognized in the Chinese Pharmacopoeia (Approval No. Z20123090), represent a widely used traditional Chinese medicine (TCM) formulation for treating acute upper respiratory tract infection (AURTI) across both pediatric and adult patients. AIM OF THE STUDY: This investigation examined XECQ's divergent regulation of endogenous metabolism and intestinal microbiome in juvenile versus mature rats, serving clinical medication to support pediatric utilization of XECQ. MATERIALS AND METHODS: AURTI model was constructed, and serum inflammatory cytokine levels, pulmonary histopathology, and immunohistochemical analysis were assessed. Young rats served as pediatric developmental proxies. Integrated serum metabolomics and 16S rDNA sequencing methodologies elucidated XECQ's systemic modulatory actions upon host metabolism and enteric microbial communities. RESULTS: XECQ manifested anti-AURTI efficacy across both age cohorts. Metabolites quantification identified 37 juvenile-specific and 18 adult-specific serum biomarkers. Additionally, XECQ modulated intestinal microbiome diversity and enhanced community richness across both age groups. Following XECQ treatment, the genera Subdoligranulum, Marvinbryantia, Anaerostipes, Bacillus, and Dubosiella_ag were significantly restored in young rats, while Escherichia-shigella, Parabacteroides, and Subdoligranulum showed notable recovery in adults. Species clustering analysis revealed distinct differences in intestinal microbiome modulation between age groups, with young rats exhibiting markedly different regulatory patterns for genera such as norank_f_Muribaculaceae, norank_f_Eubacterium_coprostanoligenes_group, Clostridium_sensu_stricto_1, and norank_f_Oscillospiraceae. In young rats, XECQ primarily regulated amino acid metabolism, notably pathways involving cysteine and methionine. In adult rats, the therapeutic effects were mainly associated with the modulation of pentose and glucuronate interconversion and purine metabolic pathways. Notably, glycerophospholipid metabolism emerged as a shared pathway across both age groups under normal conditions, during AURTI pathology, and following XECQ treatment. CONCLUSION: XECQ differentially modulates the serum metabolome and intestinal microbiome between young and adult rats, highlighting the necessity of pediatric-specific studies to support the clinical application of XECQ in children.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Chang Y, Cheng Y, et al. An integrated metabolome-microbiome analysis revealed distinct regulatory effects of Xiaoer Chiqiao Qingre granules in young versus adult rats with acute upper respiratory tract infection. J Ethnopharmacol. 2026. PMID: 41548616. doi:10.1016/j.jep.2026.121232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。